BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Obuch JC, Ahnen DJ. Colorectal Cancer: Genetics is Changing Everything. Gastroenterol Clin North Am. 2016;45:459-476. [PMID: 27546843 DOI: 10.1016/j.gtc.2016.04.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Ying Y, Xu J, Qi Y, Zhang M, Yang Y. CASP8 rs3834129 (-652 6N insertion/deletion) Polymorphism and Colorectal Cancer Susceptibility: An Updated Meta-Analysis. J Cancer 2018;9:4166-71. [PMID: 30519316 DOI: 10.7150/jca.27110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li Y, Lu Y, Chen Y. Long non-coding RNA SNHG16 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer via sponging miR-200a-3p. Biosci Rep 2019;39:BSR20182498. [PMID: 30962265 DOI: 10.1042/BSR20182498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Li HJ, Wang YL, Ming L, Guo XQ, Li YL, Wang JC, Zhang YQ, Cheng L. Development of a prognostic model based on an immunogenomic landscape analysis of colorectal cancer. Future Oncol 2021;17:301-13. [PMID: 32996773 DOI: 10.2217/fon-2020-0022] [Reference Citation Analysis]
4 Hu T, Wu X, Li K, Li Y, He P, Wu Z, Fan J, Liu W, Guan M. AKAP12 Endogenous Transcripts Suppress The Proliferation, Migration And Invasion Of Colorectal Cancer Cells By Directly Targeting oncomiR-183-5p. Onco Targets Ther 2019;12:8301-10. [PMID: 31632079 DOI: 10.2147/OTT.S207600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Liu F, Huang W, Hong J, Cai C, Zhang W, Zhang J, Kang Z. Long noncoding RNA LINC00630 promotes radio‐resistance by regulating BEX1 gene methylation in colorectal cancer cells. IUBMB Life 2020;72:1404-14. [DOI: 10.1002/iub.2263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Ozer M, Goksu SY, Sanford NN, Ahn C, Beg MS, Ali Kazmi SM. Age-dependent prognostic value of KRAS mutation in metastatic colorectal cancer. Future Oncol 2021;17:4883-93. [PMID: 34758634 DOI: 10.2217/fon-2021-0650] [Reference Citation Analysis]
7 Xiao F, Chen W, Yu C, Zhao G. MicroRNA-663b enhances migration and invasion by targeting adenomatous polyposis coli 2 in colorectal carcinoma cells. Oncol Lett 2020;19:3701-10. [PMID: 32382323 DOI: 10.3892/ol.2020.11482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yang L, Chen Z, Xiong W, Ren H, Zhai E, Xu K, Yang H, Zhang Z, Ding L, He Y, Song X, Liu J. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer. Human Pathology 2019;84:62-70. [DOI: 10.1016/j.humpath.2018.09.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Jin K, Ren C, Liu Y, Lan H, Wang Z. An update on colorectal cancer microenvironment, epigenetic and immunotherapy. Int Immunopharmacol 2020;89:107041. [PMID: 33045561 DOI: 10.1016/j.intimp.2020.107041] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ramírez-Ramírez R, Gutiérrez-Angulo M, Peregrina-Sandoval J, Moreno-Ortiz JM, Franco-Topete RA, Cerda-Camacho FJ, Ayala-Madrigal ML. Somatic deletion of KDM1A/LSD1 gene is associated to advanced colorectal cancer stages. J Clin Pathol 2020;73:107-11. [PMID: 31471467 DOI: 10.1136/jclinpath-2019-206128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
11 Partida M, Gutiérrez M, Ayala ML, Macías NM, Alvizo CR, Peregrina J. LEPR polymorphisms and haplotypes in Mexican patients with colorectal cancer. Biomedica 2019;39:205-11. [PMID: 31021558 DOI: 10.7705/biomedica.v39i1.4091] [Reference Citation Analysis]
12 Kovacs Z, Jung I, Szalman K, Banias L, Bara TJ, Gurzu S. Interaction of arylsulfatases A and B with maspin: A possible explanation for dysregulation of tumor cell metabolism and invasive potential of colorectal cancer. World J Clin Cases 2019; 7(23): 3990-4003 [PMID: 31832401 DOI: 10.12998/wjcc.v7.i23.3990] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Gong R, He Y, Liu XY, Wang HY, Sun LY, Yang XH, Li B, Cao XK, Ye ZL, Kong LH, Zhang DD, Li YH, Xu RH, Shao JY. Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients. Cancer Manag Res 2019;11:3721-39. [PMID: 31118792 DOI: 10.2147/CMAR.S193985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gong Y, Dong R, Gao X, Li J, Jiang L, Zheng J, Cui S, Ying M, Yang B, Cao J, He Q. Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota. Pharmacological Research 2019;148:104460. [DOI: 10.1016/j.phrs.2019.104460] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
15 Liu X, Wang C. Long non-coding RNA ATB is associated with metastases and promotes cell invasion in colorectal cancer via sponging miR-141-3p. Exp Ther Med 2020;20:261. [PMID: 33199986 DOI: 10.3892/etm.2020.9391] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Xu K, Chen G, Qiu Y, Yuan Z, Li H, Yuan X, Sun J, Xu J, Liang X, Yin P. miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma. Oncotarget 2017;8:21719-32. [PMID: 28423513 DOI: 10.18632/oncotarget.15559] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
17 Margetis N, Kouloukoussa M, Pavlou K, Vrakas S, Mariolis-Sapsakos T. K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas. In Vivo 2017;31:527-42. [PMID: 28652417 DOI: 10.21873/invivo.11091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Peng JJ, Meng QB, Xiao XB, Chen HT, Zhao CX, Qu ZW. Influence of KLF17 overexpression on epithelial-mesenchymal transition and invasion of SW480 colorectal cancer cells. Shijie Huaren Xiaohua Zazhi 2017; 25(3): 220-226 [DOI: 10.11569/wcjd.v25.i3.220] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Liu HH, Lee CH, Hsieh YC, Hsu DW, Cho EC. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis. Biochem Biophys Res Commun 2021;567:183-9. [PMID: 34166916 DOI: 10.1016/j.bbrc.2021.06.034] [Reference Citation Analysis]
20 Lian Y, Yan C, Ding J, Xia R, Ma Z, Hui B, Ji H, Zhou J, Wang K. A novel lncRNA, LL22NC03-N64E9.1, represses KLF2 transcription through binding with EZH2 in colorectal cancer. Oncotarget 2017;8:59435-45. [PMID: 28938648 DOI: 10.18632/oncotarget.19738] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
21 Fang H, Du Y, Pan S, Zhong M, Tang J. Patients with Parkinson's disease predict a lower incidence of colorectal cancer. BMC Geriatr 2021;21:564. [PMID: 34663210 DOI: 10.1186/s12877-021-02497-z] [Reference Citation Analysis]
22 Li Q, Xie H, Jin Z, Huang J, Wang S, Zhang Z. Overexpression of Long Noncoding RNA LBX2-AS1 Promotes the Proliferation of Colorectal Cancer. Technol Cancer Res Treat 2021;20:1533033821997829. [PMID: 33733923 DOI: 10.1177/1533033821997829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Acuña J, Piermattey J, Caro D, Bannwitz S, Barrios L, López J, Ocampo Y, Vivas-Reyes R, Aristizábal F, Gaitán R, Müller K, Franco L. Synthesis, Anti-Proliferative Activity Evaluation and 3D-QSAR Study of Naphthoquinone Derivatives as Potential Anti-Colorectal Cancer Agents. Molecules 2018;23:E186. [PMID: 29342104 DOI: 10.3390/molecules23010186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Kovač U, Skubic C, Bohinc L, Rozman D, Režen T. Oxysterols and Gastrointestinal Cancers Around the Clock. Front Endocrinol (Lausanne) 2019;10:483. [PMID: 31379749 DOI: 10.3389/fendo.2019.00483] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Chen X, Zou F, Hu Z, Du G, Yu P, Wang W, Wang H, Ye L, Tian J. PCC0208023, a potent SHP2 allosteric inhibitor, imparts an antitumor effect against KRAS mutant colorectal cancer. Toxicol Appl Pharmacol 2020;398:115019. [PMID: 32335126 DOI: 10.1016/j.taap.2020.115019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Chen MS, Lin CH, Huang LY, Qiu XM. CircRNA SMARCC1 Sponges MiR-140-3p to Regulate Cell Progression in Colorectal Cancer. Cancer Manag Res 2020;12:4899-910. [PMID: 32606978 DOI: 10.2147/CMAR.S254185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
27 Xia RM, Liu T, Li WG, Xu XQ. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA. Clin Transl Med 2021;11:e383. [PMID: 34709758 DOI: 10.1002/ctm2.383] [Reference Citation Analysis]
28 He X, Li S, Yu B, Kuang G, Wu Y, Zhang M, He Y, Ou C, Cao P. Up-regulation of LINC00467 promotes the tumourigenesis in colorectal cancer. J Cancer 2019;10:6405-13. [PMID: 31772673 DOI: 10.7150/jca.32216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
29 Ge J, Li J, Na S, Wang P, Zhao G, Zhang X. miR-548c-5p inhibits colorectal cancer cell proliferation by targeting PGK1. J Cell Physiol 2019;234:18872-8. [PMID: 30932211 DOI: 10.1002/jcp.28525] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
30 Scott A, Goffredo P, Ginader T, Hrabe J, Gribovskaja-Rupp I, Kapadia MR, Weigel RJ, Hassan I. The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database. J Gastrointest Surg 2020;24:1402-10. [PMID: 32128676 DOI: 10.1007/s11605-020-04543-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]